The Evolution of Antibody-Drug Conjugates in Oncology - Have We Found Our Magic Bullet?
Yale Cancer Center via YouTube
AI Engineer - Learn how to integrate AI into software applications
Get 20% off all career paths from fullstack to AI
Overview
Google, IBM & Meta Certificates – 40% Off
One Coursera Plus subscription covers most Professional Certificates on Coursera.
Unlock All Certificates
Join Dr. Ian Krop in this Yale Cancer Center Grand Rounds lecture exploring the fascinating evolution of Antibody-Drug Conjugates (ADCs) in cancer treatment and their potential as a "magic bullet" in oncology. Delve into the latest developments, mechanisms, and clinical applications of ADCs, examining how these targeted therapies have transformed cancer treatment approaches. Learn about the current state of ADC technology, its successes and challenges, and gain insights into future directions in this critical area of cancer therapeutics.
Syllabus
The Evolution of Antibody-Drug Conjugates in Oncology: Have we found our “Magic Bullet”? | Dr. Krop
Taught by
Yale Cancer Center